InsiderTrades.com logo
Michael L. Rankowitz net worth and biography
  • Phone
  • Email
  • Website

Michael Rankowitz Biography and Net Worth

Director of Veru

Michael L. Rankowitz was elected Director in March 2018. Mr. Rankowitz has held directorships with NF Investment Corp., Carlyle Funds, 1st Tee of Metropolitan New York, Discover Card, Clarent Hospital Corp., New York Racing Authority, International Dyslexia Association — New York Branch, Trinity School (New York) and Browning School (New York). From 1980 to 2001, Mr. Rankowitz was a managing director at Morgan Stanley, where he also served as co-head of Global High Yield and was responsible for risk management, research and sales for high yield, emerging markets, bank debt and distressed securities. He continues to be a Senior Advisor to Morgan Stanley.  He has a B.S. in mathematics from the University of Vermont.

What is Michael L. Rankowitz's net worth?

The estimated net worth of Michael L. Rankowitz is at least $49.11 thousand as of February 18th, 2025. Rankowitz owns 19,527 shares of Veru stock worth more than $49,110 as of September 25th. This net worth approximation does not reflect any other assets that Rankowitz may own. Learn More about Michael L. Rankowitz's net worth.

How do I contact Michael L. Rankowitz?

The corporate mailing address for Rankowitz and other Veru executives is 2916 N. Miami Avenue, Suite 1000, Miami, FL, 33127. Veru can also be reached via phone at (312) 595-9123 and via email at [email protected]. Learn More on Michael L. Rankowitz's contact information.

Has Michael L. Rankowitz been buying or selling shares of Veru?

Michael L. Rankowitz has not been actively trading shares of Veru during the last quarter. Most recently, on Tuesday, February 18th, Michael L. Rankowitz bought 9,527 shares of Veru stock. The stock was acquired at an average cost of $5.50 per share, with a total value of $52,398.50. Following the completion of the transaction, the director now directly owns 19,527 shares of the company's stock, valued at $107,398.50. Learn More on Michael L. Rankowitz's trading history.

Who are Veru's active insiders?

Veru's insider roster includes K Barnette (Insider), Harry Fisch (Director), Lucy Lu (Director), and Michael Rankowitz (Director). Learn More on Veru's active insiders.

Are insiders buying or selling shares of Veru?

During the last year, Veru insiders bought shares 1 times. They purchased a total of 1,800 shares worth more than $4,842.00. The most recent insider tranaction occured on August, 13th when insider K Gary Barnette bought 1,800 shares worth more than $4,842.00. Insiders at Veru own 14.2% of the company. Learn More about insider trades at Veru.

Information on this page was last updated on 8/13/2026.

Michael L. Rankowitz Insider Trading History at Veru

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/18/2025Buy9,527$5.50$52,398.5019,527View SEC Filing Icon  
See Full Table

Michael L. Rankowitz Buying and Selling Activity at Veru

This chart shows Michael L. Rankowitz's buying and selling at Veru by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Veru Company Overview

Veru logo
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $2.52
Low: $2.50
High: $2.57

50 Day Range

MA: $2.50
Low: $2.21
High: $2.80

2 Week Range

Now: $2.52
Low: $2.05
High: $7.33

Volume

78,823 shs

Average Volume

752,949 shs

Market Capitalization

$42.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A